dehydroepiandrosterone has been researched along with Acromegaly in 9 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Acromegaly: A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with bromocriptine caused a decrease in the E/A ratio in patients with decreased growth hormone levels, but not in patients in whom the growth hormone level remained unchanged." | 5.27 | The influence of bromocriptine and transsphenoidal surgery on urinary androgen metabolite excretion in acromegaly. ( Frölich, M; Moolenaar, AJ; Roelfsema, F, 1984) |
| "Serum dehydroepiandrosterone sulphate concentrations were measured in 70 patients with prolactinoma and in 54 patients with acromegaly with normal adrenocortical function." | 3.67 | Role of prolactin in age-related change in serum dehydroepiandrosterone sulphate concentrations. ( Fukushima, T; Ishibashi, M; Kamoi, K; Takaku, F; Takakura, K; Takami, M; Teramoto, A; Yamaji, T, 1989) |
| "Treatment with bromocriptine caused a decrease in the E/A ratio in patients with decreased growth hormone levels, but not in patients in whom the growth hormone level remained unchanged." | 1.27 | The influence of bromocriptine and transsphenoidal surgery on urinary androgen metabolite excretion in acromegaly. ( Frölich, M; Moolenaar, AJ; Roelfsema, F, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Hatipoglu, E | 1 |
| Hacioglu, Y | 1 |
| Polat, Y | 1 |
| Arslan, HF | 1 |
| Oner, S | 1 |
| Ekmekci, OB | 1 |
| Niyazoglu, M | 1 |
| Maggi, M | 1 |
| Buvat, J | 1 |
| Corona, G | 1 |
| Guay, A | 1 |
| Torres, LO | 1 |
| NATOLI, A | 1 |
| MAGLIOCCA, R | 1 |
| Roelfsema, F | 1 |
| Moolenaar, AJ | 1 |
| Frölich, M | 1 |
| Blevins, LS | 1 |
| Hall, GS | 1 |
| Madoff, DH | 1 |
| Laws, ER | 1 |
| Wand, GS | 1 |
| Yamaji, T | 1 |
| Ishibashi, M | 1 |
| Takaku, F | 1 |
| Teramoto, A | 1 |
| Takakura, K | 1 |
| Takami, M | 1 |
| Fukushima, T | 1 |
| Kamoi, K | 1 |
| Scurry, MT | 1 |
| Bruton, J | 1 |
| Barry, KG | 1 |
| Felt, V | 1 |
| Strasek, J | 1 |
| Bednár, J | 1 |
| Adadevoh, BK | 1 |
2 reviews available for dehydroepiandrosterone and Acromegaly
| Article | Year |
|---|---|
Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA).
Topics: Acromegaly; Adrenal Insufficiency; Dehydroepiandrosterone; Gonadotropins; Hormone Replacement Therap | 2013 |
Endocrine patterns in the African. Clinico-biochemical assessment.
Topics: Acromegaly; Adrenal Gland Diseases; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Africa; Andr | 1970 |
7 other studies available for dehydroepiandrosterone and Acromegaly
| Article | Year |
|---|---|
Do neurosteroids have impact on depression and cognitive functions in cases with acromegaly?
Topics: Acromegaly; Animals; Cognition; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression; | 2022 |
[Urinary elimination of 17-ketosteroids and dehydroisoandrosterone in patients with various endocrine diseases (Addison's disease, Cushing's disease, Cushing's syndrome, precocious puberty caused by congenital adrenal hyperplasia, acromegaly)].
Topics: 17-Ketosteroids; Acromegaly; Addison Disease; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperf | 1955 |
The influence of bromocriptine and transsphenoidal surgery on urinary androgen metabolite excretion in acromegaly.
Topics: Acromegaly; Adenoma, Acidophil; Androgens; Androsterone; Bromocriptine; Dehydroepiandrosterone; Etio | 1984 |
Case report: acromegaly and Cushing's disease in a patient with synchronous pituitary adenomas.
Topics: 17-Ketosteroids; Acromegaly; Adenoma; Adult; Cushing Syndrome; Dehydroepiandrosterone; Dehydroepiand | 1992 |
Role of prolactin in age-related change in serum dehydroepiandrosterone sulphate concentrations.
Topics: Acromegaly; Adolescent; Adult; Age Factors; Aged; Dehydroepiandrosterone; Dehydroepiandrosterone Sul | 1989 |
The effect of chorionic gonadotropin on steroid excretion.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acromegaly; Adolescent; Adult; Androsterone; Chorionic G | 1971 |
[Changes in indexes of nonbound thyroxine and of blood metabolites following administration of antiandrogens (Cyproterone), dehydroepiandrosterone, prednisone, L-triiodothyronine, D-thyroxine and in acromegaly].
Topics: 17-Hydroxycorticosteroids; Acromegaly; Adult; Binding Sites; Dehydroepiandrosterone; Female; Humans; | 1972 |